Fingerprint
Dive into the research topics of 'Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically